PA
AVY icon

PharVision Advisers’s Avery Dennison AVY Stock Holding History

PharVision Advisers’s Portfolio AVY Stock Details AVY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,540
Closed -$250K – 702
2025
Q3 		$250K Buy
+1,540
New +$265K 0.14% 330
2025
Q2 		– Sell
-2,020
Closed -$359K – 278
2025
Q1 		$359K Sell
2,020
-102
-5% -$18.8K 0.5% 67
2024
Q4 		$397K Buy
+2,122
New +$433K 0.34% 82

Other funds holding AVY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

PharVision Advisers's AVY Position: Q4 2025 in Review

PharVision Advisers sold out of Avery Dennison (AVY) in Q4 2025, closing a stake of 1,540 shares — an estimated $250K sold.

PharVision Advisers first reported a position in AVY in Q4 2024 and held it in 3 quarters. The position peaked at $397K in Q4 2024. 801 funds tracked by Wall St. Rank hold AVY as of Q4 2025.

  • PharVision Advisers reported no remaining Avery Dennison position as of Q4 2025 after selling out during the quarter.
  • PharVision Advisers sold 1,540 Avery Dennison shares in Q4 2025, an estimated $250K.
  • PharVision Advisers first reported a position in Avery Dennison in Q4 2024 and held it in 3 quarters.
  • PharVision Advisers's Avery Dennison position peaked at $397K in Q4 2024.
  • 801 funds tracked by Wall St. Rank held Avery Dennison as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.